Profile EpicentRx, Inc.
作者信息
Oronsky Bryan
机构信息
EpicentRx, Torrey Pines, CA, USA.
出版信息
Hum Vaccin Immunother. 2023 Dec 31;19(1):2184963. doi: 10.1080/21645515.2023.2184963. Epub 2023 Mar 13.
Abstract
摘要
相似文献
1
Profile EpicentRx, Inc.EpicentRx公司简介
Hum Vaccin Immunother. 2023 Dec 31;19(1):2184963. doi: 10.1080/21645515.2023.2184963. Epub 2023 Mar 13.
2
3
In silico inference of inclusion membrane protein family in obligate intracellular parasites chlamydiae.专性胞内寄生菌衣原体中包涵体膜蛋白家族的计算机模拟推断
DNA Res. 2003 Feb 28;10(1):9-17. doi: 10.1093/dnares/10.1.9.
4
Company Profile: AKESOgen, Inc.公司简介：AKESOgen，Inc.
Pharmacogenomics. 2012 Jul;13(10):1115-8. doi: 10.2217/pgs.12.87.
5
Comparisons of Neuronal and Excitatory Network Properties between the Rat Brainstem Nuclei that Participate in Vertical and Horizontal Gaze Holding.参与垂直和水平眼球凝视保持的大鼠脑干核神经元和兴奋性网络特性的比较。
eNeuro. 2017 Sep 13;4(5). doi: 10.1523/ENEURO.0180-17.2017. eCollection 2017 Sep-Oct.
6
A 12-month extension study to evaluate the safety and efficacy of asoprisnil in women with heavy menstrual bleeding and uterine fibroids.一项为期12个月的延长研究，旨在评估阿索普尼对月经过多和子宫肌瘤女性的安全性和有效性。
Hum Reprod Open. 2019 Nov 4;2019(4):hoz027. doi: 10.1093/hropen/hoz027. eCollection 2019.
7
Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study.RRx-001 治疗晚期癌症患者的安全性和活性：首次人体、开放标签、剂量递增的 1 期研究。
Lancet Oncol. 2015 Sep;16(9):1133-1142. doi: 10.1016/S1470-2045(15)00089-3. Epub 2015 Aug 19.
8
The Amigo™ Remote Catheter System: From Concept to Bedside.阿米戈™远程导管系统：从概念到床边应用
J Innov Card Rhythm Manag. 2017 Aug 15;8(8):2795-2802. doi: 10.19102/icrm.2017.080806. eCollection 2017 Aug.
9
Company Profile: Strategic Medicine, Inc. and Strategic Medicine, BV.公司简介：战略医学公司及战略医学有限公司。
Per Med. 2013 Sep;10(7):633-637. doi: 10.2217/pme.13.62.
10
fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy.磁共振功能成像研究大麻二酚治疗耐药性癫痫患者注意力控制的变化。
Epilepsy Behav. 2019 Jul;96:114-121. doi: 10.1016/j.yebeh.2019.04.008. Epub 2019 May 24.
引用本文的文献
1
Hypothesis: AdAPT-001 and pseudoprogression - when seeing is not necessarily believing.假说：AdAPT-001 和假性进展——眼见不一定为实。
J Immunother Cancer. 2024 Jun 17;12(6):e008809. doi: 10.1136/jitc-2024-008809.
2
Data Management 101 for drug developers: A peek behind the curtain.药物开发者的数据管理 101：一探幕后。
Clin Transl Sci. 2023 Sep;16(9):1497-1509. doi: 10.1111/cts.13582. Epub 2023 Jul 6.
3
RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist.RRx-001：一种嵌合型三重作用的NLRP3抑制剂、Nrf2诱导剂和一氧化氮超激动剂。
Front Oncol. 2023 May 29;13:1204143. doi: 10.3389/fonc.2023.1204143. eCollection 2023.
Zotero 插件